Pharmaceutical composition for oral application and method for preparing thereof
The present invention relates to a pharmaceutical composition for oral application comprising: i) an anthelmintic agent; ii) a first excipient having a porous structure with an inner surface of about 500 to 1500 m 2 /g and a surface area according to BET of up to about 5000 m 2 /g; as well as to a method of preparing such a composition.
1. A pharmaceutical composition for oral application comprising:
(a) an anthelmintic agent;
(b) a first taste-masking excipient having a porous structure with an inner surface of about 1400 to about 2100 m2/g wherein absorption of the anthelmintic agent occurs and a surface area according to Brunauer Emmett Teller method of up to about 5000 m2/g; and
(c) a second excipient adsorbed to the core of the first excipient,
wherein the anthelmintic agent is selected from the group consisting of ivermection, febantel, fenbendazol, praziquantel, epsiprantel and mixtures thereof,
wherein the first excipient is charcoal or activated charcoal present in an amount of about 50% to about 70% by weight and having the agent adsorbed has a particle size of less than 50 μm, and
wherein the second excipient is colloidal silicon dioxide.
2. The pharmaceutical composition according to claim 1 , wherein the agent is adsorbed to the inner pores of the excipient.
3. The pharmaceutical composition according to claim 1 , wherein the first excipient is mucoadhesive in the gastrointestinal tract.
4. The pharmaceutical composition according to claim 1 , wherein the pharmaceutical composition is coated or encapsulated.
5. The pharmaceutical composition according to claim 1 , wherein the pharmaceutical composition further comprises adjuvants, flavours, and/or diluents.
6. A method of preparing a pharmaceutical composition according to claim 1 , comprising the step of mixing the agent and the first and or second excipient in a dry state,
wherein the method of preparation is solvent-free.
7. The method according to claim 6 , wherein the mixing is carried out under agitation with high speed.
8. The method according to claim 6 , wherein the second excipient is first adsorbed to the core of the first excipient prior to the mixing step.
9. The pharmaceutical composition according to claim 1 wherein the charcoal has a surface area according to the Brunauer Emmett Teller method of 1700 m2/g.